Patents by Inventor Christopher J. Montague Meade

Christopher J. Montague Meade has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Tiotropium-containing pharmaceutical combination for inhalation
    Patent number: 7250426
    Abstract: The present invention relates to new pharmaceutical compositions for inhalation containing one or more, preferably one, tiotropium salt combined with one or more pharmacologically acceptable acid addition salts of a compound of formula 2?, wherein the groups R1, R2, R3 and R4 may have the meanings given in the claims and in the specification, processes for preparing them and their use in the treatment of respiratory complaints.
    Type: Grant
    Filed: November 19, 2003
    Date of Patent: July 31, 2007
    Assignee: Boehringer Ingelheim Pharma GmbH & Co KG
    Inventors: Ingo Konetzki, Christopher J. Montague Meade, Michel Pairet, Michael P. Pieper
  • Pharmaceutical compositions based on anticholinergic and dopamine agonists
    Publication number: 20040161386
    Abstract: The present invention relates to novel pharmaceutical compositions based on anticholinergics and dopamine agonists, processes for preparing them and their use in the treatment of respiratory tract diseases.
    Type: Application
    Filed: February 10, 2004
    Publication date: August 19, 2004
    Applicant: Boehringer Ingelheim Pharma KG
    Inventors: Michel Pairet, Michael P. Pieper, Christopher J. Montague Meade
  • Tiotropium-containing pharmaceutical combination for inhalation
    Publication number: 20040132759
    Abstract: The present invention relates to new pharmaceutical compositions for inhalation containing one or more, preferably one, tiotropium salt combined with one or more pharmacologically acceptable acid addition salts of a compound of formula 2′, 1
    Type: Application
    Filed: November 19, 2003
    Publication date: July 8, 2004
    Applicant: Boehringer Ingelheim Pharma GmbH & Co. KG
    Inventors: Ingo Konetzki, Christopher J. Montague Meade, Michel Pairet, Michael P. Pieper
  • Compositions and methods for treating cystic fibrosis
    Publication number: 20030181518
    Abstract: A method of treating or preventing cystic fibrosis in a patient in need of such treatment, the method comprising administering to the patient a therapeutically effective amount of an LTB4 antagonist of formula (I) 1
    Type: Application
    Filed: April 15, 2003
    Publication date: September 25, 2003
    Applicant: Boehringer Ingelheim Pharma KG
    Inventors: Ralf Anderskewitz, Christopher J. Montague Meade, Franz Birke, Hans Michael Jennewein, Birgit Jung
  • Use of an LTB4 antagonist for the treatment or prevention of diseases caused by increased expression of mucin genes
    Patent number: 6576669
    Abstract: Medicaments and pharmaceutical kits comprising an LTB4 antagonist of formula (I) a tautomer thereof or a pharmaceutically acceptable salt thereof, and methods of treating or preventing cystic fibrosis, diseases caused by increased expression of mucin genes in the bronchial or gastrointestinal epithelium, or hyperplasia of goblet cells induced by toxins of products of pathogenic bacteria in a patient in need of such treatment, the method comprising administering to the patient a therapeutically effective amount of an LTB4 antagonist of formula (I).
    Type: Grant
    Filed: January 16, 2002
    Date of Patent: June 10, 2003
    Assignee: Boehringer Ingelheim Pharma KG
    Inventors: Ralf Anderskewitz, Christopher J. Montague Meade, Franz Birke, Hans Michael Jennewein, Birgit Jung
  • Use of an LTB4 antagonist for the treatment or prevention of diseases caused by increased expression of mucin genes
    Publication number: 20020137792
    Abstract: Medicaments and pharmaceutical kits comprising an LTB4 antagonist of formula (I) 1
    Type: Application
    Filed: January 16, 2002
    Publication date: September 26, 2002
    Inventors: Ralf Anderskewitz, Christopher J. Montague Meade, Franz Birke, Hans Michael Jennewein, Birgit Jung
  • Pharmaceutical compositions based on anticholinergics and dopamine agonists
    Publication number: 20020122773
    Abstract: The present invention relates to novel pharmaceutical compositions based on anticholinergics and dopamine agonists, processes for preparing them and their use in the treatment of respiratory tract diseases.
    Type: Application
    Filed: December 20, 2001
    Publication date: September 5, 2002
    Inventors: Michel Pairet, Michael P. Pieper, Christopher J. Montague Meade